FDA lifts hold on second Intellia Phase 3 gene editing trialnews2026-03-02T15:23:14+00:00March 2nd, 2026|Endpoints News|
UniQure says FDA prefers randomized trial for Huntington’s treatmentnews2026-03-02T12:35:27+00:00March 2nd, 2026|Endpoints News|
Merck looks to expand Welireg label following combo readouts with Keytruda, Lenvimanews2026-02-28T15:00:54+00:00February 28th, 2026|Endpoints News|
Ascendis wins FDA approval for achondroplasia drug, waits on EU actionnews2026-02-27T22:52:42+00:00February 27th, 2026|Endpoints News|
Synergy Spine Solutions Earns FDA Approval for the Synergy Disc, Advancing Cervical Disc Replacement in the U.S.news2026-02-27T14:36:07+00:00February 27th, 2026|Medical Device News Magazine|
FDA probes internal Prasad complaints with outside helpnews2026-02-26T20:13:02+00:00February 26th, 2026|Endpoints News|
Boehringer wins accelerated approval for first-line use of lung cancer drugnews2026-02-26T20:03:47+00:00February 26th, 2026|Endpoints News|
Senate hearing raises FDA-related concerns for new rare disease drugsnews2026-02-26T19:27:02+00:00February 26th, 2026|Endpoints News|
HHS commits up to $144M to study anti-aging approaches via ARPA-Hnews2026-02-24T20:46:28+00:00February 24th, 2026|Endpoints News|
Patient dies in MacroGenics’ cancer study, FDA puts trial on holdnews2026-02-24T15:40:28+00:00February 24th, 2026|Endpoints News|
